A Randomised Trial Of Zoledronic Acid For Osteoarthritis Of The Knee
Funder
National Health and Medical Research Council
Funding Amount
$989,238.00
Summary
Osteoarthritis (OA) is the most common form of arthritis and is increasing markedly due to an ageing population. Despite its large disease burden, there are currently no approved disease-modifying drugs available which modify structural progression of OA. The aim of this study is to compare zoledronic acid treatment to placebo on knee structural change and knee pain over two years. It is hypothesised that zoledronic acid will reduce cartilage loss, knee pain, and bone marrow lesion size.
Unloading Shoes For Knee Osteoarthritis: A Double-blind Randomised Controlled Trial
Funder
National Health and Medical Research Council
Funding Amount
$772,743.00
Summary
This is a clinical trial that will evaluate the effectiveness of unloading shoes for managing the symptoms of knee osteoarthritis. This trial will evaluate whether unloading shoes can reduce pain and physical dysfunction, compared to control (non-unloading) shoes, after 6 months. Patient characteristics that may influence the effectiveness of the unloading shoes will also be evaluated. If effective, unloading shoes could be made commercially available as a self-management strategy to patients wi ....This is a clinical trial that will evaluate the effectiveness of unloading shoes for managing the symptoms of knee osteoarthritis. This trial will evaluate whether unloading shoes can reduce pain and physical dysfunction, compared to control (non-unloading) shoes, after 6 months. Patient characteristics that may influence the effectiveness of the unloading shoes will also be evaluated. If effective, unloading shoes could be made commercially available as a self-management strategy to patients with knee osteoarthritis .Read moreRead less
ENDOGENOUS PAIN RELIEF IN HEALTHY AND OSTEOARTHRITIC PATIENTS
Funder
National Health and Medical Research Council
Funding Amount
$509,926.00
Summary
Pain has a detrimental impact on ones quality of life and a significant financial impact on the community. Given this, there is a substantial effort aimed at developing pain relieving compounds. One way in which our own brain can provide complete pain relief is via a mechanism called diffuse noxious inhibitory control. We currently do not know how this mechanism works and the aim of this investigation is to explore this mechanism in healthy and osteoarthritis patients use human brain imaging.
Femoroacetabular impingement (FAI) is a common cause of hip pain characterised by extra bone formation at the hip, called a cam-deformity. FAI is thought to create hip joint damage and osteoarthritis. Our 5 year longitudinal study of people with FAI in two (Melbourne and Brisbane) sites will investigate whether factors (such as cam-deformity size, hip contact force, muscle strength and joint range) can predict hip joint damage (measured with magnetic resonance imaging) over two years.
Hype Or Hope? Platelet-Rich Plasma As A Symptom- And DisEaSe-modifying Treatment FOR Knee OstEoarthritis - The RESTORE Trial
Funder
National Health and Medical Research Council
Funding Amount
$1,400,359.00
Summary
Knee osteoarthritis (OA) is a major public health problem worldwide with no cure. Thus safe and effective treatments that reduce symptoms and slow structural disease progression are needed. This clinical trial aims to test the effects of injections of platelet-rich plasma (a blood product) into the knee on pain and joint structure in 288 people with knee OA. The results will provide high quality evidence to determine whether platelet rich plasma should be used to treat knee OA.
Does Low Dose Amitriptyline Reduce Pain In Knee Osteoarthritis? A Double Blind, Randomised, Pragmatic, Placebo Controlled Clinical Trial Of Amitriptyline In Addition To Usual Care
Funder
National Health and Medical Research Council
Funding Amount
$413,704.00
Summary
Pain is the main problem for people with osteoarthritis, a common form of arthritis. This pain is not controlled well. Pain comes from structural changes in the joint. However, after time, some people develop pain due to changes in the nervous system, called pain sensitisation. This is not affected by usual treatments. Amitriptyline is used to treat pain sensitisation. This study is a randomised trial to see whether amitriptyline, relieves pain in people with knee osteoarthritis over 3 months.
Footwear For Self-managing Knee Osteoarthritis Symptoms: The Footstep Trial
Funder
National Health and Medical Research Council
Funding Amount
$590,532.00
Summary
Self-management of symptoms is an important part of treatment for people with knee osteoarthritis. Footwear influences forces across the knee joint and it is unclear which types of shoes are best to minimise arthritis symptoms. This study will compare the effects of flat flexible shoes to stable supportive shoe styles on pain and physical function over 6 months in people with painful knee osteoarthritis.
Prevention And Treatment Of Bone Infection With CSA-90
Funder
National Health and Medical Research Council
Funding Amount
$350,983.00
Summary
Bone infections are a major challenge to treat, especially with the rise of drug resistant “superbugs”. We have access to a new agent, CSA-90, that has dual properties of being anti-microbial (antibiotic) and helps encourage bone growth. This project aims to expand upon our prior research and test CSA-90 for the treatment of chronic bone infections. We will also look at applying this technology to joint replacements and this drug may be particularly useful for coating orthopaedic implants.
Can Shoe Inserts Reduce The Burden Of Kneecap Osteoarthritis?
Funder
National Health and Medical Research Council
Funding Amount
$644,550.00
Summary
Kneecap arthritis is a leading cause of pain, disability and health expenditure in the Australian community. ‘Off-the-shelf’ shoe inserts are simple, low-cost devices that can reduce kneecap pain in young adults, and are accessible to all Australians. This project investigates whether ‘off-the-shelf’ shoe inserts improve pain in older adults with kneecap arthritis over 12 months, and evaluates the relationship between cost and patient benefits.
Efficacy Of Education And Advice Delivered By Text Message To Aid Smoking Cessation
Funder
National Health and Medical Research Council
Funding Amount
$538,395.00
Summary
A high proportion of smokers indicate a desire to stop smoking and report having made attempts to quit. However, most attempts are not successful and new methods are needed to support motivated smokers and improve success rates. This project evaluates the use of text messages to deliver advice and support to smokers motivated to stop smoking. We aim to understand if and how this promosing new intervention helps smokers to quit.